Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/8548
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis
Ana Carolina Pereira Nunes Pinto
Aline Pereira Rocha
Keilla Machado Martins Milby
Cesar Ramos Rocha-Filho
Felipe Reis
Nelson Carvas Junior
Vinicius Civile
Rodolfo Rodrigo Pereira Santos
Giulia Trevisani
Laura Jantsch Ferla
Gabriel Ramalho
Maria Eduarda dos Santos Puga
Virginia Trevisani
Alvaro Nagib Atallah
Acceso Abierto
Atribución-NoComercial-SinDerivadas
https://doi.org/10.1101/2020.05.02.20088823
https://www.medrxiv.org/content/10.1101/2020.05.02.20088823v1
CONTEXT AND OBJECTIVE Coronavirus disease 2019 (COVID-19) has emerged in China in December 2019 and rapidly spread. Although extraordinary efforts have been made on research regarding pharmacological interventions, none have proven effective. This is the protocol for a rapid living systematic review that aims to compare the effectiveness and safety of different pharmacological interventions for the treatment of COVID-19. METHODS rapid living systematic review methodology with Network Meta-Analysis following the recommendations of Cochrane Handbook. We will include randomized controlled trials (RCT) and quasi-RCTs that evaluate single and/or combined pharmacological interventions at any dose for the treatment of COVID-19. We will search PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), LILACS, Scopus and SciELO to identify potentially eligible studies. No language restrictions will be used in the selection. We will perform the critical appraisal of included studies with the Risk of Bias tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
bioRxiv
06-05-2020
Preimpreso
Inglés
Público en general
VIRUS RESPIRATORIOS
Aparece en las colecciones: Materiales de Consulta y Comunicados Técnicos

Cargar archivos: